Marilyn Dysart, PhD is the Clinical Affairs Manager at PharmaJet, Inc., a medical device company in Golden, Colorado that has developed Needle-Free Injection technologies. Prior to joining PharmaJet, Marilyn worked as a Clinical Research Manager at the University of Colorado and held positions at several biotechnology companies focused in molecular and cellular research and medical device development. Marilyn spent the beginning of her career as a scientist contributing to teams developing new wound healing products and then transitioned to subsequent project management roles within the biotechnology industry, specializing in novel drug development. Marilyn has broad experience in molecular biology, tissue engineering, and materials science. Marilyn’s doctoral research at Georgia Institute of Technology focused on cell and tissue engineering and understanding the mechanisms of epithelial to mesenchymal transition within the pulmonary microenvironment. She received her Bachelor of Science degree in Biomedical Engineering from the University of Virginia, where she studied tissue engineering in mouse models of the human cardiovascular system.